Randomized clinical trial (RCT) to study the clinical efficacy and safety of new platelet products using platelet additive solutions are scarce. In this paper a number of recent RCT's is discussed. It can be the start of a development where new transfusion products enter a RCT before the product is applied in clinical practice.

Additional Metadata
Persistent URL dx.doi.org/10.1016/j.transci.2007.02.004, hdl.handle.net/1765/36843
Citation
van Rhenen, D.J. (2007). Clinical use of platelet additive solutions. Transfusion and Apheresis Science, 37(3), 269–272. doi:10.1016/j.transci.2007.02.004